We have previously shown that the overexpression of ASM sensitized glioma cells to cytostatic therapy [20] while chronic hepatitis C infection and non-alcoholic fatty liver disease is associated with an increased serologic ASM activity [21]. The gene discussed is SMPD1; the disease is metabolic dysfunction-associated steatotic liver disease.